Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2516 | 2148 | 36.0 | 70% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LAMOTRIGINE | Author keyword | 174 | 33% | 20% | 440 |
2 | FELBAMATE | Author keyword | 165 | 72% | 6% | 130 |
3 | OXCARBAZEPINE | Author keyword | 91 | 40% | 8% | 179 |
4 | ANTIEPILEPTIC DRUGS | Author keyword | 45 | 13% | 15% | 320 |
5 | TRILEPTAL | Author keyword | 17 | 100% | 0% | 8 |
6 | POLYTHERAPY | Author keyword | 12 | 29% | 2% | 35 |
7 | MONOTHERAPY TRIALS | Author keyword | 12 | 86% | 0% | 6 |
8 | MONOTHERAPY | Author keyword | 11 | 12% | 4% | 90 |
9 | NEW ANTIEPILEPTIC DRUGS | Author keyword | 9 | 41% | 1% | 17 |
10 | CAS 84057 84 1 | Author keyword | 6 | 80% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LAMOTRIGINE | 174 | 33% | 20% | 440 | Search LAMOTRIGINE | Search LAMOTRIGINE |
2 | FELBAMATE | 165 | 72% | 6% | 130 | Search FELBAMATE | Search FELBAMATE |
3 | OXCARBAZEPINE | 91 | 40% | 8% | 179 | Search OXCARBAZEPINE | Search OXCARBAZEPINE |
4 | ANTIEPILEPTIC DRUGS | 45 | 13% | 15% | 320 | Search ANTIEPILEPTIC+DRUGS | Search ANTIEPILEPTIC+DRUGS |
5 | TRILEPTAL | 17 | 100% | 0% | 8 | Search TRILEPTAL | Search TRILEPTAL |
6 | POLYTHERAPY | 12 | 29% | 2% | 35 | Search POLYTHERAPY | Search POLYTHERAPY |
7 | MONOTHERAPY TRIALS | 12 | 86% | 0% | 6 | Search MONOTHERAPY+TRIALS | Search MONOTHERAPY+TRIALS |
8 | MONOTHERAPY | 11 | 12% | 4% | 90 | Search MONOTHERAPY | Search MONOTHERAPY |
9 | NEW ANTIEPILEPTIC DRUGS | 9 | 41% | 1% | 17 | Search NEW+ANTIEPILEPTIC+DRUGS | Search NEW+ANTIEPILEPTIC+DRUGS |
10 | CAS 84057 84 1 | 6 | 80% | 0% | 4 | Search CAS+84057+84+1 | Search CAS+84057+84+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RESISTANT PARTIAL SEIZURES | 134 | 86% | 3% | 68 |
2 | PREVIOUSLY UNTREATED EPILEPSY | 104 | 73% | 4% | 80 |
3 | NEWLY DIAGNOSED EPILEPSY | 72 | 35% | 8% | 164 |
4 | CARBAMAZEPINE | 55 | 11% | 22% | 474 |
5 | SECONDARILY GENERALIZED SEIZURES | 54 | 74% | 2% | 40 |
6 | BW430C | 48 | 91% | 1% | 20 |
7 | TONIC CLONIC SEIZURES | 47 | 28% | 7% | 145 |
8 | POTENTIAL ANTIEPILEPTIC DRUG | 45 | 68% | 2% | 40 |
9 | LAMOTRIGINE | 40 | 15% | 11% | 244 |
10 | FELBAMATE MONOTHERAPY | 40 | 72% | 1% | 31 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes | 2006 | 286 | 95 | 49% |
Safety review of adult clinical trial experience with lamotrigine | 1998 | 146 | 21 | 86% |
Clinical pharmacokinetics of oxcarbazepine | 2003 | 86 | 67 | 81% |
The importance of drug interactions in epilepsy therapy | 2002 | 208 | 122 | 32% |
Drug Interaction and Pharmacokinetic Modeling of Oxcarbazepine in Korean Patients With Epilepsy | 2012 | 7 | 16 | 88% |
Antiepileptic drug therapy the story so far | 2010 | 49 | 42 | 38% |
Drug interactions involving the new second- and third-generation antiepileptic drugs | 2010 | 58 | 112 | 32% |
Clinically relevant drug interactions with antiepileptic drugs | 2006 | 191 | 66 | 30% |
The new antiepileptic drugs - Scientific review | 2004 | 135 | 102 | 54% |
Antiepileptic drugs as a cause of worsening seizures | 1998 | 247 | 64 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KINDERKLIN KIDRON | 3 | 100% | 0.1% | 3 |
2 | NIJMEGEN EPILEPSY GRP | 3 | 100% | 0.1% | 3 |
3 | PHARMACOL THER EUT UNIT | 3 | 19% | 0.6% | 12 |
4 | CHILDRENS COMPREHENS EPILEPSY PROGRAM | 2 | 38% | 0.2% | 5 |
5 | ZENTRUM EPILEPSIE | 2 | 36% | 0.2% | 5 |
6 | CATEDRATICO FARMACOL CLIN | 2 | 67% | 0.1% | 2 |
7 | JEFE SERV FARMACOL CLIN | 2 | 67% | 0.1% | 2 |
8 | NANTONG UNIV LIB | 2 | 67% | 0.1% | 2 |
9 | CENT NERVOUS SYST CLIN | 1 | 50% | 0.1% | 2 |
10 | CLIN PHARMACOL SERV PHYSIOL PHARMACOL | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000290301 | TOPIRAMATE//TOPIRAMATE TOPAMAX//TOPIRAMATE TOXICITY |
2 | 0.0000274364 | VIGABATRIN//VISUAL FIELD CONSTRICTION//GAMMA VINYL GABA |
3 | 0.0000267728 | LACOSAMIDE//ESLICARBAZEPINE ACETATE//PERAMPANEL |
4 | 0.0000201274 | ZONISAMIDE//NEUROSCI MOL BIOL//CA2 INDUCED CA2 RELEASING SYSTEM |
5 | 0.0000200557 | RUFINAMIDE//CLOBAZAM//LENNOX GASTAUT SYNDROME |
6 | 0.0000200438 | LEVETIRACETAM//SV2A//BRIVARACETAM |
7 | 0.0000190083 | FIRST SEIZURE//SEIZURE RELAPSE//FIRST EPILEPTIC SEIZURE |
8 | 0.0000169078 | CARBAMAZEPINE 10 11 EPOXIDE//FREE PHENYTOIN//R 4PK |
9 | 0.0000135885 | LATE ONSET SEIZURES//STROKE RELATED SEIZURES//POST STROKE EPILEPSY |
10 | 0.0000123857 | GABAPENTIN//PREGABALIN//NEURONTIN |